Komori
Genova (9341) · FactAdvanced

Increase in Shares Outstanding and Capital Through the Exercise of Stock Acquisition Rights

First written in FY2024-Q1. 6 of 8 entries say "Advanced", first in FY2024-Q2. Latest entry: FY2026.

8entries
4years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2024-Q2 – FY2026-H12023: 220232024: 220242025: 220252026: 22026
Same theme, other companies
Ongoing Increases in Capital and Capital Reserve Through the Exercise of Stock Acquisition RightsA theme 169 companies write about · 0 as a headwind · 164 as a tailwind

103 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 169 companies compared. The sentences above are computed from all 169.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「1 April 2025–31 March 2026 31,000 17,837,600 4,715 779,201 4,715 679,201 (Note) Increase resulting from the exercise of stock acquisition rights.」

    The exercise of stock acquisition rights increased the total number of shares issued by 31,000 and increased share capital and the capital reserve by ¥4.715 million each.
  2. 2026-06-01Cited as achievedGeneral Meetings of Shareholders

    「Common shares 17,806,600 shares 31,000 shares − shares 17,837,600 shares」

    The Company reported an increase of 31,000 common shares resulting from the exercise of stock acquisition rights during the fiscal year.
  3. FY2026-H1AdvancedAnnual report

    「1 April 2025–30 September 2025 20,000 17,826,600 3,102 777,588 3,102 677,588 (Note) Increase resulting from the exercise of stock acquisition rights.」

    The exercise of stock acquisition rights increased the total number of shares issued by 20,000 and increased share capital and the capital reserve by ¥3.102 million each.
  4. FY2025AdvancedAnnual report

    「1 April 2024–31 March 2025 12,500 17,806,600 1,244 774,486 1,244 674,486 (Note) Increase resulting from the exercise of stock acquisition rights.」

    The exercise of stock acquisition rights increased the total number of shares issued by 12,500 and increased share capital and the capital reserve by ¥1.244 million each.
  5. FY2025-H1AdvancedAnnual report

    「1 April 2024–30 September 2024 2,500 17,796,600 619 773,861 619 673,861 (Note) Increase resulting from the exercise of stock acquisition rights.」

    The exercise of stock acquisition rights increased the total number of shares issued by 2,500 and increased share capital and the capital reserve by ¥619,000 each.
  6. FY2024-Q3AdvancedAnnual report

    「At the end of the third quarter of the current consolidated fiscal year, total net assets were ¥5,186.532 million, an increase of ¥1,139.658 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥11.5 million in share capital and ¥11.5 million in capital surplus resulting from the issuance of new shares, and an increase in retained earnings resulting from the recording of ¥947.444 million in net income attributable to owners of the parent.」

    The issuance of new shares increased share capital and capital surplus by ¥11.5 million each, bringing total net assets to ¥5,186.532 million.
  7. FY2024-Q2AdvancedAnnual report

    「At the end of the second quarter of the current consolidated fiscal year, total net assets were ¥4,814.982 million, an increase of ¥768.108 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥10.125 million in share capital and ¥10.125 million in capital surplus resulting from the exercise of stock acquisition rights, an increase of ¥118.570 million in stock acquisition rights, and an increase in retained earnings resulting from the recording of ¥626.011 million in net income attributable to owners of the parent.」

    The exercise of stock acquisition rights increased share capital and capital surplus by ¥10.125 million each, bringing total net assets to ¥4,814.982 million.
  8. FY2024-Q1First statedAnnual report

    「This was mainly due to an ¥8 million increase in share capital and an ¥8 million increase in capital surplus, primarily resulting from the exercise of stock acquisition rights, a ¥50.081 million increase in stock acquisition rights, and an increase in retained earnings resulting from the recording of ¥288.884 million in net income attributable to owners of the parent.」

    During the quarter, the total number of shares issued increased by 128,000 through the exercise of stock acquisition rights, while share capital and the capital reserve each increased by ¥8 million.
Moved together

"Development of an Online Medical Consultation System and New Products" moved the same way as this thread, in the same document, in 6 of its 8 moves.

655554★123456
  1. ★This thread
  2. 1Development of an Online Medical Consultation System and New Products6×
  3. 2Introduction of smart self-service payment and repeat-visit check-in machines and expansion of contracts5×
  4. 3Investment in Recruitment, Training and Development to Support Business Expansion5×
  5. 4Increase in employee numbers accompanying business expansion5×
  6. 5Improving Order Volume and Profit Margins Through Value-Added Products5×
  7. 6Providing Access to Appropriate Medical Information to Promote Healthy Life Expectancy4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Genova yet. It last moved in the General Meetings of Shareholders of 2026-06-01: "Cited as achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Increase in Shares Outstanding and Capital Through the Exercise of Stock Acquisition Rights | GENOVA,Inc. (9341) | Komori